Clinical Trials Directory

Trials / Completed

CompletedNCT00692523

Effectiveness of Virtual Reality Exercises in STroke Rehabilitation (EVREST)

A Pilot Randomised, Two Parallel Group Study Comparing Wii Gaming Versus Recreational Activity in Patients Receiving Standard Rehabilitation After Stroke

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Unity Health Toronto · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

This study is a pilot, randomized trial that will examine whether the Nintendo Wii virtual gaming system is safe and feasible for use in patients who have had a recent stroke.

Detailed description

A pilot, randomized (1:1) controlled trial to compare the safety and feasibility of Nintendo Wii gaming versus other recreational therapy activities (playing cards) in post-stroke patients. All patients will continue to receive all other standard medical and physiotherapy treatments while in the study.

Conditions

Interventions

TypeNameDescription
OTHERRecreational therapy activitiesRecreational therapy sessions will include leisure activities such as playing cards and/or doing arts and crafts.
OTHERNintendo WiiThe Nintendo Wii gaming system, released in 2005, introduced a new style of virtual reality by using a wireless controller that interacts with the player through a motion detection system. Nintendo Wii involves the incorporation of 3-dimensional accelerometer technology that can respond to changes in direction, speed, and acceleration, down to the most delicate movements. Specifically, the controllers use embedded acceleration sensors to enable players' wrist, arm, and hand movements to interact with the games. Tilt measurements allow users to move characters, while the accurate three-axis acceleration sensing easily transforms the controller into a virtual sword, gearshift, or musical instrument

Timeline

Start date
2008-11-01
Primary completion
2009-10-01
Completion
2009-10-01
First posted
2008-06-06
Last updated
2009-10-02

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT00692523. Inclusion in this directory is not an endorsement.